(CercleFinance.com) – Lumibird suffered one of the biggest declines on the Parisian market on Friday after having reassessed, a few weeks before the end of the financial year, its financial objectives for 2024.
The laser technology specialist now says it expects annual turnover of at least 200 million euros, i.e. organic growth of at least 5%, lower than the 8% announced at the start of the year and confirmed at the end of October. .
In a press release, the group mentions postponements of deliveries linked to technical delays in the qualification and production of certain products, as well as postponements of orders for regulatory reasons or due to schedule adjustments by customers.
The company indicates that it also suffered from persistent unfavorable currency effects in the 4th quarter.
The downward revision of its annual turnover forecast will mechanically impact its operating margin (Ebitda), now expected to exceed 17%, i.e. below the 20% previously announced.
At 2:20 p.m., Lumibird fell by almost 15% in a slightly rising Parisian market (+0.4% on average). Since the start of the year, the stock has fallen more than 32%.
Resulting from the merger in 2017 between Quantel and Keopsys, Lumibird manufactures high-performance lasers for scientific (research laboratories, universities), industrial (production, defense/space, Lidar sensors) and medical (ophthalmology, ultrasound diagnosis) uses.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
Are you following this action?
Receive all the information on LUMIBIRD in real time: